Cargando…

N-Glycans: Phenotypic Homology and Structural Differences between Myocardial Cells and Induced Pluripotent Stem Cell-Derived Cardiomyocytes

Cell surface glycans vary widely, depending on cell properties. We hypothesized that glycan expression on induced pluripotent stem cells (iPSCs) might change during cardiomyogenic differentiation toward the myocardial phenotype. N-glycans were isolated from iPSCs, iPSC-derived cardiomyocytes (iPSC-C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kawamura, Takuji, Miyagawa, Shigeru, Fukushima, Satsuki, Yoshida, Akira, Kashiyama, Noriyuki, Kawamura, Ai, Ito, Emiko, Saito, Atsuhiro, Maeda, Akira, Eguchi, Hiroshi, Toda, Koichi, Lee, Jong-Kook, Miyagawa, Shuji, Sawa, Yoshiki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4214687/ https://www.ncbi.nlm.nih.gov/pubmed/25357199 http://dx.doi.org/10.1371/journal.pone.0111064

Ejemplares similares

Maturation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes by Soluble Factors from Human Mesenchymal Stem Cells
por: Yoshida, Shohei, et al.
Publicado: (2018)

Syngeneic Mesenchymal Stem Cells Reduce Immune Rejection After Induced Pluripotent Stem Cell-Derived Allogeneic Cardiomyocyte Transplantation
por: Yoshida, Shohei, et al.
Publicado: (2020)

Publisher Correction: Syngeneic Mesenchymal Stem Cells Reduce Immune Rejection After Induced Pluripotent Stem Cell-Derived Allogeneic Cardiomyocyte Transplantation
por: Yoshida, Shohei, et al.
Publicado: (2020)

Cardiomyocytes Derived from MHC-Homozygous Induced Pluripotent Stem Cells Exhibit Reduced Allogeneic Immunogenicity in MHC-Matched Non-human Primates
por: Kawamura, Takuji, et al.
Publicado: (2016)

Teratocarcinomas Arising from Allogeneic Induced Pluripotent Stem Cell-Derived Cardiac Tissue Constructs Provoked Host Immune Rejection in Mice
por: Kawamura, Ai, et al.
Publicado: (2016)

Vasculogenically conditioned peripheral blood mononuclear cells inhibit mouse immune response to induced pluripotent stem cell-derived allogeneic cardiac grafts
por: Kashiyama, Noriyuki, et al.
Publicado: (2019)

Development of PET Imaging to Visualize Activated Macrophages Accumulated in the Transplanted iPSc-Derived Cardiac Myocytes of Allogeneic Origin for Detecting the Immune Rejection of Allogeneic Cell Transplants in Mice
por: Kashiyama, Noriyuki, et al.
Publicado: (2016)

Pivotal Role of Non-cardiomyocytes in Electromechanical and Therapeutic Potential of Induced Pluripotent Stem Cell-Derived Engineered Cardiac Tissue
por: Iseoka, Hiroko, et al.
Publicado: (2018)

Building A New Treatment For Heart Failure-Transplantation of Induced Pluripotent Stem Cell-derived Cells into the Heart
por: Miyagawa, Shigeru, et al.
Publicado: (2016)

Acute Coronary Syndrome Requiring Coronary Artery Bypass Grafting in a Patient With Sotos Syndrome
por: Murakami, Takashi, et al.
Publicado: (2021)

Chimerism through the activation of invariant natural killer T cells prolongs graft survival after transplantation of induced pluripotent stem cell–derived allogeneic cardiomyocytes
por: Yoshida, Shohei, et al.
Publicado: (2022)

Immunologic targeting of CD30 eliminates tumourigenic human pluripotent stem cells, allowing safer clinical application of hiPSC-based cell therapy
por: Sougawa, Nagako, et al.
Publicado: (2018)

Transplantation of Human-induced Pluripotent Stem Cell-derived Cardiomyocytes Is Superior to Somatic Stem Cell Therapy for Restoring Cardiac Function and Oxygen Consumption in a Porcine Model of Myocardial Infarction
por: Ishida, Masaru, et al.
Publicado: (2019)

Establishment of a protocol to administer immunosuppressive drugs for iPS cell-derived cardiomyocyte patch transplantation in a rat myocardial infarction model
por: Ito, Emiko, et al.
Publicado: (2023)

Enhanced Therapeutic Effects of Human iPS Cell Derived-Cardiomyocyte by Combined Cell-Sheets with Omental Flap Technique in Porcine Ischemic Cardiomyopathy Model
por: Kawamura, Masashi, et al.
Publicado: (2017)

Impact of tricuspid regurgitation on late right ventricular failure in left ventricular assist device patients ~can prophylactic tricuspid annuloplasty prevent late right ventricular failure? ~
por: Nakazato, Taro, et al.
Publicado: (2021)

Impella Support as a Bridge to Surgery for Severe Mitral Regurgitation With Cardiogenic Shock
por: Imaoka, Shusuke, et al.
Publicado: (2021)

Successful Radical Pericardiectomy for Porcelain Constrictive Pericarditis
por: Hamada, Yusuke, et al.
Publicado: (2021)

Evaluation of right ventricular function using liver stiffness in patients with left ventricular assist device†
por: Kashiyama, Noriyuki, et al.
Publicado: (2017)

Case report: Transplantation of human induced pluripotent stem cell-derived cardiomyocyte patches for ischemic cardiomyopathy
por: Miyagawa, Shigeru, et al.
Publicado: (2022)

Safety confirmation of induced pluripotent stem cell-derived cardiomyocyte patch transplantation for ischemic cardiomyopathy: first three case reports
por: Kawamura, Takuji, et al.
Publicado: (2023)

Laminin‐221 Enhances Therapeutic Effects of Human‐Induced Pluripotent Stem Cell–Derived 3‐Dimensional Engineered Cardiac Tissue Transplantation in a Rat Ischemic Cardiomyopathy Model
por: Samura, Takaaki, et al.
Publicado: (2020)

Active infective endocarditis of a bicuspid aortic valve causing left ventricular outflow tract pseudoaneurysm and right atrium shunt: A case report
por: Mikami, Tsubasa, et al.
Publicado: (2021)

Irradiation strongly reduces tumorigenesis of human induced pluripotent stem cells
por: Inui, Shoki, et al.
Publicado: (2017)

Natural killer cells impede the engraftment of cardiomyocytes derived from induced pluripotent stem cells in syngeneic mouse model
por: Nakamura, Yuki, et al.
Publicado: (2019)

A sustained-release drug-delivery system of synthetic prostacyclin agonist, ONO-1301SR: a new reagent to enhance cardiac tissue salvage and/or regeneration in the damaged heart
por: Fukushima, Satsuki, et al.
Publicado: (2015)

Development of In Vitro Drug-Induced Cardiotoxicity Assay by Using Three-Dimensional Cardiac Tissues Derived from Human Induced Pluripotent Stem Cells
por: Takeda, Maki, et al.
Publicado: (2018)

Development of a vitrification method for preserving human myoblast cell sheets for myocardial regeneration therapy
por: Ohkawara, Hirotatsu, et al.
Publicado: (2018)

Sustained-Release Delivery of Prostacyclin Analogue Enhances Bone Marrow-Cell Recruitment and Yields Functional Benefits for Acute Myocardial Infarction in Mice
por: Imanishi, Yukiko, et al.
Publicado: (2013)

Enhanced Pulmonary Vascular and Alveolar Development via Prenatal Administration of a Slow-Release Synthetic Prostacyclin Agonist in Rat Fetal Lung Hypoplasia
por: Umeda, Satoshi, et al.
Publicado: (2016)

Notch Signaling-Modified Mesenchymal Stem Cell Patch Improves Left Ventricular Function via Arteriogenesis Induction in a Rat Myocardial Infarction Model
por: Maeda, Shusaku, et al.
Publicado: (2023)

Eliminating residual iPS cells for safety in clinical application
por: Masuda, Shigeo, et al.
Publicado: (2015)

Clinical Outcomes of Autologous Stem Cell–Patch Implantation for Patients With Heart Failure With Nonischemic Dilated Cardiomyopathy
por: Domae, Keitaro, et al.
Publicado: (2021)

Human induced pluripotent stem cell-derived three-dimensional cardiomyocyte tissues ameliorate the rat ischemic myocardium by remodeling the extracellular matrix and cardiac protein phenotype
por: Yokoyama, Junya, et al.
Publicado: (2021)

Secondary abdominal compartment syndrome required decompression laparotomy during minimally invasive mitral valve repair
por: Nishi, Hiroyuki, et al.
Publicado: (2016)

Xeno‐pericardial patch repair of the inferior vena cava for radical resection of renal cell carcinoma with tumor thrombus
por: Fukushima, Satsuki, et al.
Publicado: (2017)

Engineered three-dimensional cardiac tissues maturing in a rotating wall vessel bioreactor remodel diseased hearts in rats with myocardial infarction
por: Nakazato, Taro, et al.
Publicado: (2022)

Enhanced myocardial blood flow in ischemic cardiomyopathy by a slow-release synthetic prostacyclin agonist combined with coronary artery bypass grafting: The first human study in a Phase I/IIa clinical trial
por: Kawamura, Takuji, et al.
Publicado: (2023)

Prediction of aortic valve regurgitation after continuous-flow left ventricular assist device implantation using artificial intelligence trained on acoustic spectra
por: Misumi, Yusuke, et al.
Publicado: (2021)

Tumorigenicity assay essential for facilitating safety studies of hiPSC-derived cardiomyocytes for clinical application
por: Ito, Emiko, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_b645if6msunl5e87ov7vvochp2